Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageAlign Technology, Inc. (“we,” “us,” “our,” “Align” or the “Company”) is a global medical device company primarily engaged in the design, manufacture and marketing of Invisalign® clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (“GPs”), ViveraTM retainers for retention, iTeroTM intraoral scanners and services for dentistry, and exocadTM computer-aided design and computer-aided manufacturing (“CAD/CAM”) software for dental laboratories and dental practitioners.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Business segments
Jun 2026 · $1.06BThe company’s own SEC segment disclosure.
- Clear Aligner$870.9M82%
- Systems And Services$185.3M18%
Align Technology (ALGN) reported revenue of $1.04B in Q1 2026 (quarter ended Mar 31, 2026), up 6.2% from the same quarter a year earlier. That came with a gross margin of 71% and net income of $113M (11% of revenue). For the full year FY2025, revenue was $4.03B (+0.9% year on year) and net income $410M. Its largest segment in Jun 2026 was Clear Aligner at $871M, 82% of the disclosed total, well ahead of Systems And Services at 18%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
The closest names by size in the same industry